Personalized RNA Medicine for Pancreatic Cancer

Personalized RNA Medicine for Pancreatic Cancer

Purpose: Since drug responses vary between patients, it is crucial to develop pre-clinical or co-clinical strategies that forecast patient response. In this study, we tested whether RNA-based therapeutics were suitable for personalized medicine by using patient-derived-organoid (PDO) and patient-der...

Full description

Bibliographic Details
Main Authors: Gilles, Maud-Emmanuelle (Author), Hao, Liangliang (Author), Huang, Ling (Author), Rupaimoole, Rajesha (Author), Lopez-Casas, Pedro P. (Author), Pulver, Emilia M (Author), Jeong, Jong Cheol (Author), Muthuswamy, Senthil K. (Author), Hidalgo, Manuel (Author), Bhatia, Sangeeta N (Author), Slack, Frank J. (Author)
Other Authors: Massachusetts Institute of Technology. Institute for Medical Engineering & Science (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Association for Cancer Research (AACR), 2020-12-18T16:53:28Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items